127 related articles for article (PubMed ID: 38698701)
1. Potential role of oxidative stress in pathogenesis of benign prostatic hyperplasia in male dogs.
Domosławska-Wyderska A; Zduńczyk S; Rafalska A
Reprod Domest Anim; 2024 May; 59(5):e14580. PubMed ID: 38698701
[TBL] [Abstract][Full Text] [Related]
2. Periodontitis Exacerbates Benign Prostatic Hyperplasia through Regulation of Oxidative Stress and Inflammation.
Fang C; Wu L; Zhao MJ; Deng T; Gu JM; Guo XP; Li C; Li W; Zeng XT
Oxid Med Cell Longev; 2021; 2021():2094665. PubMed ID: 34707774
[TBL] [Abstract][Full Text] [Related]
3. The effect of benign prostatic hyperplasia on total antioxidant capacity and protein peroxidation in canine prostatic fluid and spermatozoa.
Domosławska A; Zduńczyk S; Bielecka A; Kankofer M
Pol J Vet Sci; 2023 Dec; 26(4):667-673. PubMed ID: 38088310
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress promotes benign prostatic hyperplasia.
Vital P; Castro P; Ittmann M
Prostate; 2016 Jan; 76(1):58-67. PubMed ID: 26417670
[TBL] [Abstract][Full Text] [Related]
5. The influence of benign prostatic hyperplasia on sperm morphological features and sperm DNA integrity in dogs.
Flores RB; Angrimani D; Rui BR; Brito MM; Abreu RA; Vannucchi CI
Reprod Domest Anim; 2017 Apr; 52 Suppl 2():310-315. PubMed ID: 27774660
[TBL] [Abstract][Full Text] [Related]
6. Development of canine benign prostatic hyperplasia with age.
Berry SJ; Strandberg JD; Saunders WJ; Coffey DS
Prostate; 1986; 9(4):363-73. PubMed ID: 2431402
[TBL] [Abstract][Full Text] [Related]
7. [Experimental research on spontaneous benign prostatic hyperplasia in old dogs].
Cai RF; Cui YG; Hua LX; Jia Y; Ma DZ; Wang XH
Zhonghua Nan Ke Xue; 2003 Dec; 9(9):651-3, 657. PubMed ID: 14727348
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in benign prostatic hyperplasia: a systematic review.
Minciullo PL; Inferrera A; Navarra M; Calapai G; Magno C; Gangemi S
Urol Int; 2015; 94(3):249-54. PubMed ID: 25503259
[TBL] [Abstract][Full Text] [Related]
9. Testicular steroids, prolactin, relaxin and prostate gland markers in peripheral blood and seminal plasma of normal dogs and dogs with prostatic hyperplasia.
Wolf K; Kayacelebi H; Urhausen C; Piechotta M; Mischke R; Kramer S; Einspanier A; Oei CH; Günzel-Apel A
Reprod Domest Anim; 2012 Dec; 47 Suppl 6():243-6. PubMed ID: 23279510
[TBL] [Abstract][Full Text] [Related]
10. Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH-induced dogs with an anti-proliferative agent called tadalafil.
Dearakhshandeh N; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Abbaszadeh Hasiri M; Golchin-Rad K
J Vet Pharmacol Ther; 2019 Nov; 42(6):665-672. PubMed ID: 31410874
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 90 is associated with hyperplasia and neoplastic transformation of canine prostatic epithelial cells.
Palmieri C; Mancini M; Benazzi C; Della Salda L
J Comp Pathol; 2014 May; 150(4):393-8. PubMed ID: 24679854
[TBL] [Abstract][Full Text] [Related]
12. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
13. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
Trachtenberg J; Hicks LL; Walsh PC
J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
[TBL] [Abstract][Full Text] [Related]
14. Changes in the Serum Prostatic Biomarkers During the Treatment of Benign Prostatic Hyperplasia with a 5alpha-reductase Inhibitor: Finasteride.
Golchin-Rad K; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Derakhshandeh N; Abbaszadeh-Hasiri M
Top Companion Anim Med; 2020 Mar; 38():100405. PubMed ID: 32115076
[TBL] [Abstract][Full Text] [Related]
15. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs.
Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI
Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate.
Brendler CB; Berry SJ; Ewing LL; McCullough AR; Cochran RC; Strandberg JD; Zirkin BR; Coffey DS; Wheaton LG; Hiler ML; Bordy MJ; Niswender GD; Scott WW; Walsh PC
J Clin Invest; 1983 May; 71(5):1114-23. PubMed ID: 6189857
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in prostate hyperplasia and carcinogenesis.
Udensi UK; Tchounwou PB
J Exp Clin Cancer Res; 2016 Sep; 35(1):139. PubMed ID: 27609145
[TBL] [Abstract][Full Text] [Related]
18. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
Isaacs JT; Coffey DS
Endocrinology; 1981 Feb; 108(2):445-53. PubMed ID: 6161001
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia.
Schulze H; Barrack ER
Prostate; 1987; 11(2):145-62. PubMed ID: 2444954
[TBL] [Abstract][Full Text] [Related]
20. The association between the serum concentration of canine prostate specific esterase (CPSE) and the size of the canine prostate.
Holst BS; Holmroos E; Friling L; Hanås S; Langborg LM; Franko MA; Hansson K
Theriogenology; 2017 Apr; 93():33-39. PubMed ID: 28257864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
